Insulin analogue insulin pump combined clinical observation of treatment of type 2 diabetes.docVIP

 PAGE \* MERGEFORMAT 7 Insulin analogue insulin pump combined clinical observation of treatment of type 2 diabetes [Abstract] Objective To compare continuous subcutaneous insulin infusion pump insulin analogues (CSII and multiple injections of insulin analogues (MSII patients with type 2 diabetes clinical effect and safety. METHODS 130 patients with type 2 diabetes were randomly divided into the treatment group by using insulin aspart continuous subcutaneous pump implantation, control group of 30 special charge aspart subcutaneous injection meal, 2 times daily. Results CSII blood glucose control and insulin standard number of days the amount was less than MSII group, CSII group, a lower incidence of hypoglycemia. Conclusion CSII blood glucose control is the ideal method. [Keywords:] insulin analogue, insulin pump, type 2 diabetes With the improvement of living standards, rapidly rising incidence of diabetes, diabetes treatment issue has become a global study. Oral drug treatment of diabetic patients with diabetes can not meet the requirements of the pursuit of quality of life, the clinical application of insulin treatment for diabetes opens new ground in pursuit of the use of insulin pump for diabetes patients with high quality of life opens the door. In order to observe the insulin analogues and insulin in the pump [1], the clinical effect observed in our hospital from 2005-2007, 130 cases of type 2 the treatment of diabetic patients, summarized as follows. 1 Materials and Methods 1.1 General information on 130 cases of patients, male 68 cases, female 62 cases, aged 38 to 72 years, mean 58 years, mean disease duration was 7.6 years. According to 1999 WHO diagnostic criteria for diagnosis of type 2 diabetes. Randomly divided into insulin analogues and insulin in pump therapy group (66 cases and the control group (64 patients, two groups of age, gender, disease duration, body mass index in the difference was not statistically significant. 1.2 M